| Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management |
Globe Newswire |
06/25 |
07:30 |
| Lycia Therapeutics Raises $75 Million in Oversubscribed Financing and Strengthens Leadership Team with Appointment of Chief Financial Officer and General Counsel |
Globe Newswire |
06/25 |
07:30 |
| NuCube Energy to Become a Publicly Listed Company Through Business Combination with Launch Two Acquisition Corp. |
Globe Newswire |
06/25 |
07:20 |
| Digital Currency X Technology Enters Into Securities Purchase Agreement for a Private Placement of US$700 Million of Units, Payable in U.S. Dollars or Digital Assets, to Advance Its Digital Asset Treasury Strategy |
Globe Newswire |
06/25 |
07:18 |
| Flash Sports & Media (Nasdaq: FLZH) Announces Planned Launch of Zimbabwe T20 League (ZT20) |
Globe Newswire |
06/25 |
07:05 |
| Winnebago Industries Reports Third Quarter Fiscal 2026 Results |
Globe Newswire |
06/25 |
07:00 |
| Verano to Report Second Quarter 2026 Financial Results on August 5, 2026 |
Globe Newswire |
06/25 |
07:00 |
| Troilus Drills 157.5 Metres Grading 0.95 g/t AuEq While Targeting Inferred Material Within the Z87 Reserve Pit |
Globe Newswire |
06/25 |
07:00 |
| INmune Bio Inc. Achieves MHRA Approval of PIP for CORDStrom™ |
Globe Newswire |
06/25 |
07:00 |
| Kymera Therapeutics Completes Enrollment in the Phase 2b BROADEN2 Trial of KT-621 in Atopic Dermatitis with Topline Data by Year-end 2026 |
Globe Newswire |
06/25 |
07:00 |
| Impact Analytics Research Identifies Holiday 2026's Defining Promotional Strategy: Broader Reach, Disciplined Depth |
Globe Newswire |
06/25 |
07:00 |
| Highlander Silver: Comprehensive Geophysical Program Maps Extensive System Concealed by Shallow Cover at Corani |
Globe Newswire |
06/25 |
07:00 |
| Montauk Brewing Kicks Off Summer with 14th Anniversary Celebration, Limited Brew Barn Release and Beach Cleanup |
Globe Newswire |
06/25 |
07:00 |
| Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial |
Globe Newswire |
06/25 |
07:00 |
| Initial Lightbridge Fuel™ Material Samples Removed from Idaho National Laboratory’s Advanced Test Reactor |
Globe Newswire |
06/25 |
07:00 |
| Herantis appoints experienced drug development expert Dr Juha Savola as Chief Medical Officer |
Globe Newswire |
06/25 |
07:00 |
| Satellos to Present Clinical Program Updates at ICNMD 2026 |
Globe Newswire |
06/25 |
07:00 |
| GDS Concludes Successful 2026 Annual General Meeting with All Resolutions Passed, Including Election and Re-election of Directors |
Globe Newswire |
06/25 |
07:00 |
| Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus |
Globe Newswire |
06/25 |
07:00 |
| NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System |
Globe Newswire |
06/25 |
07:00 |
| Baker Hughes to Deliver Subsea Production Systems to Support Azule Energy’s Greater PAJ Development |
Globe Newswire |
06/25 |
07:00 |
| Treno Scope Launches “Data for All” Initiative, Empowering Developers in Vietnam and Thailand |
Globe Newswire |
06/25 |
06:55 |
| Finance Complaint List Launches Comprehensive Fraud Recovery Platform to Combat Online Stock-Trading |
Globe Newswire |
06/25 |
06:51 |
| Adobe Introduces Firefly Foundry to Support Custom AI Models for Enterprise Brand Consistency |
Globe Newswire |
06/25 |
06:42 |
| Leads Biolabs Announces Partner Oblenio Bio’s $62 Million Oversubscribed Series B Financing to Advance Tri-Specific T-Cell Engager LBL‑051 for Autoimmune Diseases into Clinical Development |
Globe Newswire |
06/25 |
06:38 |
